Sumitomo Mitsui Trust Group Inc. Makes New Investment in Healthpeak Properties, Inc. (NYSE:DOC)

Sumitomo Mitsui Trust Group Inc. acquired a new position in Healthpeak Properties, Inc. (NYSE:DOC) during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 4,486,881 shares of the real estate investment trust’s stock, valued at approximately $102,615,000. Sumitomo Mitsui Trust Group Inc. owned approximately 0.64% of Healthpeak Properties as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently made changes to their positions in DOC. abrdn plc purchased a new stake in shares of Healthpeak Properties in the third quarter worth $62,670,000. Douglas Lane & Associates LLC purchased a new stake in Healthpeak Properties during the third quarter valued at about $33,947,000. Foresight Group Ltd Liability Partnership purchased a new stake in Healthpeak Properties during the third quarter valued at about $33,212,000. Asset Management One Co. Ltd. purchased a new stake in Healthpeak Properties during the third quarter valued at about $29,934,000. Finally, Raymond James & Associates purchased a new stake in Healthpeak Properties during the third quarter valued at about $25,711,000. Hedge funds and other institutional investors own 93.57% of the company’s stock.

Healthpeak Properties Stock Down 0.6 %

NYSE DOC opened at $21.65 on Thursday. The company has a debt-to-equity ratio of 0.93, a current ratio of 1.31 and a quick ratio of 1.31. The stock has a market capitalization of $15.14 billion, a PE ratio of 46.06, a PEG ratio of 2.43 and a beta of 1.13. Healthpeak Properties, Inc. has a 1 year low of $16.01 and a 1 year high of $23.26. The business’s 50-day moving average is $22.30 and its 200 day moving average is $21.03.

Healthpeak Properties (NYSE:DOC) last issued its quarterly earnings data on Thursday, October 24th. The real estate investment trust reported $0.12 EPS for the quarter, missing the consensus estimate of $0.44 by ($0.32). Healthpeak Properties had a return on equity of 3.53% and a net margin of 12.10%. The company had revenue of $700.40 million during the quarter, compared to analysts’ expectations of $682.51 million. During the same quarter last year, the business earned $0.45 earnings per share. The business’s quarterly revenue was up 25.9% on a year-over-year basis. Sell-side analysts forecast that Healthpeak Properties, Inc. will post 1.8 earnings per share for the current year.

Healthpeak Properties Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Monday, November 4th will be issued a $0.30 dividend. The ex-dividend date is Monday, November 4th. This represents a $1.20 annualized dividend and a yield of 5.54%. Healthpeak Properties’s dividend payout ratio (DPR) is presently 255.32%.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the company. Deutsche Bank Aktiengesellschaft upgraded Healthpeak Properties from a “hold” rating to a “buy” rating and raised their price target for the company from $20.00 to $28.00 in a research report on Monday, October 21st. Scotiabank raised their price objective on Healthpeak Properties from $23.00 to $24.00 and gave the company a “sector outperform” rating in a research note on Monday, September 9th. Robert W. Baird raised their price objective on Healthpeak Properties from $24.00 to $25.00 and gave the company an “outperform” rating in a research note on Wednesday, October 30th. Royal Bank of Canada raised their price objective on Healthpeak Properties from $25.00 to $26.00 and gave the company an “outperform” rating in a research note on Monday, November 4th. Finally, Citigroup raised their price objective on Healthpeak Properties from $20.00 to $22.00 and gave the company a “neutral” rating in a research note on Thursday, August 22nd. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, Healthpeak Properties presently has an average rating of “Moderate Buy” and a consensus price target of $22.86.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.